Insulin Lispro vs PACAP-27

Head-to-head comparison of Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) and PACAP-27 (Pituitary Adenylate Cyclase-Activating Polypeptide-27) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin LisproPACAP-27
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameInsulin lispro (B28-Lys, B29-Pro human insulin analog)Pituitary Adenylate Cyclase-Activating Polypeptide-27
Molecular Weight5808.0 Da3158 Da
Half-LifeAbout 1 hourminutes
Amino Acids5127
Typical Dose0.05-0.2 U/kg per mealResearch-only: 0.1-1 nmol/kg
RouteSubcutaneousIntraperitoneal/Subcutaneous
Purity≥98%≥98%
Studies Count12000220
Research StatusApprovedPre-clinical

Insulin Lispro Benefits

  • Rapid postprandial glucose control
  • Flexible premeal timing
  • Predictable onset of action
  • Useful in basal-bolus regimens

PACAP-27 Benefits

  • anti-apoptotic signaling
  • insulin secretagogue effect
  • reduced ER stress
  • islet cytoprotection

Insulin Lispro Dosing

Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin

PACAP-27 Dosing

0.1-1 nmol/kg in animal studies|10-100 nM in vitro|research-only intermittent dosing

Insulin Lispro Side Effects

  • Hypoglycemia
  • Weight gain
  • Injection-site reactions

PACAP-27 Side Effects

  • flushing
  • hypotension at high exposure
  • headache

Research Overview

Insulin Lispro

Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.

PACAP-27

PACAP-27 has been repeatedly shown to support beta-cell survival through cAMP/PKA and related pathways. In experimental models it mitigates cytokine damage, preserves insulin content, and helps maintain islet viability.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Lispro stacks with:

Insulin GlargineInsulin Degludec

PACAP-27 stacks with:

GLP-1 analogsDPP-4 inhibitorsdiet and exercise
rapid-acting insulinprandial controlglucose regulationneuropeptidebeta-cell protectioncAMP signaling